Ovid Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.3 | 2.2 | 1.8 | 1.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 49.0 | 11.7 | 1.2 | 0.6 | 0.5 | 348.9 | – | – | – | 89.1 | 1,485.4 | 1,173.3 | 905.7 | 577.0 | 462.5 | 96.4 | 134.8 | 117.1 | 40.4 | 3.5 | 14.0 | 18.0 | 22.8 | 125.8 | |
| – | – | – | 1.9 | 2.3 | 2.9 | 2.4 | 3.1 | 2.8 | 1.5 | 1.0 | 1.6 | 4.1 | 2.9 | 3.2 | 13.5 | 5.3 | 3.4 | 1.2 | 1.3 | 1.2 | 1.2 | 1.3 | 1.0 | 0.9 | 1.0 | 1.5 | 2.1 | 2.6 | 2.6 | 2.8 | 0.6 | 1.1 | 1.0 | 0.4 | 0.4 | 2.1 | 1.0 | 0.8 | 0.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.6 | 980.9 | 817.0 | 716.0 | 511.2 | 400.3 | 46.4 | 113.1 | 73.0 | 4.3 | -0.5 | 11.1 | 16.4 | 9.8 | 119.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.1 | 2.1 | 2.0 | 1.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -12.5% | -13.4% | -13.0% | -21.4% | -22.4% | -31.3% | -77.7% | -83.9% | -62.4% | -36.7% | -24.9% | -34.8% | -15.2% | -16.1% | -35.3% | 47.9% | 47.4% | 50.2% | 54.3% | -28.7% | -37.3% | -47.0% | -42.3% | -26.5% | -19.7% | -16.1% | -20.3% | -23.0% | -96.7% | -68.0% | -84.5% | -223.8% | -170.8% | -41.1% | -29.3% | -25.9% | -27.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 51.5% | 50.6% | 33,306.7% | – | – | – | 70.7% | -257.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.5% | 97.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,115.2% | -645.4% | 52.2% | 28.9% | 30.5% | 19,868.3% | – | – | – | -3,696.4% | -43,906.8% | -27,240.8% | -17,978.2% | -15,122.7% | -13,039.2% | -11,998.4% | -10,972.8% | -10,933.2% | -10,404.2% | -625.0% | -618.3% | -585.2% | -670.2% | -3,686.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,098.9% | -642.3% | 52.0% | 28.4% | 30.0% | 19,784.4% | – | – | – | -3,604.7% | -41,673.0% | -24,819.1% | -16,377.0% | -13,351.8% | -10,691.4% | -5,237.3% | -5,142.6% | -4,670.0% | -4,557.1% | -574.0% | -549.6% | -240.1% | -339.3% | -2,178.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -787.9% | -411.9% | 57.7% | 29.2% | 27.4% | 18,942.7% | – | – | – | -3,767.5% | -39,397.3% | -23,073.0% | -14,558.5% | -11,685.9% | -10,630.4% | -9,324.6% | -9,163.1% | -9,898.8% | -9,051.5% | -602.7% | -574.2% | -528.6% | -589.1% | -3,460.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -32.5% | -45.5% | -125.1% | -57.3% | -66.1% | -77.7% | -60.7% | -76.0% | -100.1% | -134.0% | -91.9% | -116.0% | -187.7% | -86.3% | -129.6% | -249.9% | -119.4% | -185.7% | 52.0% | 58.9% | 64.4% | 68.8% | -41.5% | -44.2% | -47.7% | -41.0% | -42.5% | -44.5% | -47.9% | -59.6% | -64.7% | -33.5% | -42.6% | -38.7% | -42.1% | -68.4% | -81.3% | -13.3% | -12.2% | -16.4% | |
| -31.0% | -42.3% | -112.2% | -53.5% | -62.9% | -72.4% | -55.6% | -67.7% | -82.9% | -109.1% | -78.9% | -96.0% | -138.6% | -74.8% | -108.0% | -168.0% | -82.9% | -106.7% | 48.4% | 55.9% | 61.2% | 63.6% | -35.8% | -37.9% | -41.1% | -34.9% | -35.9% | -36.1% | -38.8% | -36.3% | -38.5% | -25.2% | -31.7% | -28.7% | -30.6% | -49.3% | -56.9% | -11.5% | -10.7% | -14.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | -44 | -106 | -96 | -87 | -29 | -23 | -31 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -128 | -62 | -71 | -56 | -26 | -30 | -28 | -14 | -25 | -20 | -27 | -19 | -12 | -93 | -9.8 | |
| 95.4% | 93.0% | 89.7% | 93.5% | 95.3% | 93.3% | 91.6% | 89.1% | 82.7% | 81.4% | 85.9% | 82.8% | 73.8% | 86.6% | 83.3% | 67.2% | 69.5% | 57.5% | 93.1% | 94.8% | 95.1% | 92.4% | 86.3% | 85.8% | 86.1% | 85.2% | 84.4% | 81.3% | 81.0% | 61.0% | 59.5% | 75.3% | 74.3% | 74.0% | 72.6% | 72.1% | 70.0% | 86.6% | 87.9% | 90.5% | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.93 | -1.14 | -2.15 | -3.19 | -2.50 | -2.63 | -1.78 | -1.89 | -2.03 | -2.11 | -1.73 | -1.36 | -1.46 | -1.23 | -1.22 | -1.37 | -1.28 | -1.27 | 1.73 | 1.80 | 1.87 | 1.81 | -0.97 | -0.96 | -0.96 | -0.77 | -0.73 | -0.70 | -0.69 | -0.74 | -0.72 | -0.42 | -0.46 | -0.37 | -0.35 | -0.54 | -0.51 | -0.21 | -0.33 | -0.47 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.20 | 3.32 | 6.33 | 6.22 | 0.01 | -2.93 | -5.89 | -5.89 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.09 | 0.09 | 0.09 | 0.10 | 0.02 | |
| 2.85 | 2.51 | 1.72 | 5.57 | 3.78 | 3.39 | 2.93 | 2.48 | 2.03 | 1.58 | 1.89 | 1.17 | 0.78 | 1.42 | 0.94 | 0.55 | 1.07 | 0.68 | 3.32 | 3.05 | 2.90 | 2.64 | 2.35 | 2.16 | 2.02 | 1.88 | 1.72 | 1.57 | 1.43 | 1.24 | 1.11 | 1.25 | 1.07 | 0.96 | 0.83 | 0.78 | 0.63 | 1.60 | 2.69 | 2.85 | |
| -0.73 | -0.92 | -0.87 | -1.31 | -1.15 | -1.28 | -1.52 | -1.75 | -1.78 | -1.86 | -1.51 | -1.19 | -1.17 | -1.04 | -1.04 | -1.12 | -0.92 | -0.81 | 1.92 | 1.85 | 1.71 | 1.74 | -0.89 | -0.82 | -0.85 | -0.80 | -0.69 | -0.65 | -0.61 | -0.65 | -0.71 | -0.74 | -0.82 | -0.79 | -0.70 | -0.56 | -0.53 | -0.47 | -0.57 | -0.74 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.